New Jersey A 2771: Provides that persons between 18 and 21 years of age with disabilities are eligible to receive direct support professional services from DHS.

Bill Text

A2771 

ASSEMBLY, No. 2771 

STATE OF NEW JERSEY

222nd LEGISLATURE

� 

PRE-FILED FOR INTRODUCTION IN THE 2026 SESSION

Sponsored by:

Assemblywoman ANDREA KATZ

District 8 (Atlantic and Burlington)

Co-Sponsored by:

Assemblyman Danielsen

SYNOPSIS

���� Permits import of prescription drugs from certain 
countries.

CURRENT VERSION OF TEXT 

���� Introduced Pending Technical Review by Legislative 
Counsel.

�� 

An Act concerning certain prescription drugs and supplementing 
Title 24 of the Revised Statutes.

���� Be It 
Enacted by the Senate and General Assembly of 
the State of New Jersey:

���� 1.��� As used in this act: 

���� �Commissioner,� �department,� 
�drug,� and �wholesale distributor� shall have the same meaning as prescribed 
for those terms in section 5 of P.L.2005, c.206 (C.24:6B-14). 

���� �Foreign countries� means 
Canada and any other foreign nation that uses similarly high standards to 
regulate prescription drugs, as determined by the commissioner. 

���� �Health benefits plan� shall 
have the same meaning as prescribed for that term in section 2 of P.L.1997, 
c.192 (C.26:2S-2).

���� 2.��� a.� The commissioner, in 
consultation with stakeholders and appropriate federal officials, shall 
establish a wholesale prescription drug importation program that complies with 
the applicable requirements of 21 U.S.C. s.384, and any other applicable federal 
requirements, including the requirements regarding safety and cost savings, 
within 120 days after the effective date of this act.� The program shall: 

���� (1)� designate one or more 
entities that shall either become a wholesaler distributor or contract with a 
wholesaler distributor in order to seek federal certification and approval to 
import safe prescription drugs and provide significant prescription drug cost 
savings to State consumers; 

���� (2)� use drug suppliers 
located in foreign countries; 

���� (3)� import only those 
prescription drugs that meet the U.S. Food and Drug Administration�s 
requirements for safety and effectiveness; and

���� (4)� import only those 
prescription drugs that are expected to generate substantial savings for State 
consumers.

���� b.��� An entity designated 
pursuant to subsection a. of this section shall:

���� (1)� become a wholesale 
distributor or enter into a contract with a wholesale distributor;� 

���� (2)� contract with one or more 
licensed and regulated suppliers located in foreign countries; 

���� (3)� develop a registration 
process for health benefits plans, pharmacies, and prescription 
drug-administering health care providers who are willing to participate in the 
wholesale prescription drug importation program; 

���� (4)� create a publicly 
available source for listing the prices of imported prescription drug products 
that shall be made available to all participating entities and consumers; 

���� (5)� create an outreach and 
marketing plan to generate program awareness; 

���� (6)� create and staff a 
telephone hotline to answer questions and address the needs of consumers, 
employers, health benefits plans, pharmacies, health care providers, and other 
affected entities; 

���� (7)� establish a biennial 
audit performed by a third-party entity that is not the department or an 
affiliate of the entity designated pursuant to subsection a. of this section; 
and 

���� (8)� conduct any other 
activities that the commissioner determines to be important for successful 
implementation of the program.

���� 3.��� a.� Within 210 days 
after the effective date of this act, the commissioner shall submit a formal 
request to the Secretary of the federal Department of Health and Human Services 
for certification of the State�s wholesale prescription drug importation program. 

���� b.��� The commissioner shall 
seek the appropriate federal approvals, waivers, exemptions, or agreements, or 
a combination thereof, as needed to enable as many State consumers as possible 
to benefit from cost savings produced by the wholesale prescription drug importation 
program.

���� 4.��� This act shall take 
effect 30 days after the date of enactment.

STATEMENT

���� This bill permits the import of 
prescription drugs from certain countries.

���� Under the bill, the 
Commissioner of Health (commissioner), in consultation with interested 
stakeholders and appropriate federal officials, is to establish a wholesale 
prescription drug importation program (program) that complies with applicable 
federal requirements.� The program is to: (1) designate one or more entities 
that are wholesale distributors or that contract with a wholesale distributor 
in order to seek federal certification and approval to import safe prescription 
drugs and provide significant prescription drug cost savings to State 
consumers; (2) use prescription drug suppliers located in foreign countries; 
(3) import only those prescription drugs that meet the U.S. Food and Drug 
Administration�s requirements for safety and effectivenes